Monthly Archives

May 2026

Acral Dermoscopy: ODAC in the News

By Media Coverage, Uncategorized

acral dermoscopy

The challenge of diagnosing acral lesions—those found on the palms and soles—is a familiar one for even the most seasoned dermatologists. Because these areas follow a unique set of “rules” compared to the rest of the body, clinical confidence is paramount to avoiding unnecessary biopsies while catching early-stage melanomas.

The Dermatology Digest highlights an ODAC session on the topic presented by Jennifer Stein, MD, PhD, FAAD, professor and associate vice chair at the NYU Grossman School of Medicine. The article outlines Dr. Stein’s actionable, everyday strategies, including:

  • The Golden Rule: “Furrows are Fine, Ridges are Risky”
  • Acquired Acral Three-Step Algorithm
  • The BRAAFF Algorithm

In the article, Dr. Stein also shares some considerations in patients with darker skin types:

  • Most algorithms may not perfectly translate to patients with darker skin tones.
  • In Fitzpatrick Skin Types V and VI, clinicians may encounter physiologic volar melanocytic macules that display parallel ridge patterns but are entirely benign. While these findings are common in skin of color, Dr. Stein cautioned that the “index of suspicion” must remain high to ensure acral melanoma isn’t overlooked.

Evaluating the nail unit presents its own set of hurdles, as the pigment often originates in the difficult-to-biopsy nail matrix. Dr. Stein breaks down the evaluation into two categories:

  • Non-melanocytic: Before suspecting a tumor, rule out fungal infections (look for a “reverse triangle” pattern) and subungual hemorrhages (look for red-to-black spots with filamentous edges).
  • Melanocytic: Benign ethnic melanonychia often presents with gray, homogeneous lines. However, the “Ugly Duckling” concept is your best friend here. Look for outliers: bands that are wider at the base, involve multiple colors, or cause nail plate destruction.

Dermoscopy is an invaluable tool, but it works best when paired with clinical intuition. By mastering the distinction between furrows and ridges and remaining mindful of how these patterns shift across different skin types, clinicians can provide more accurate, confident care for their patients.

Read the original article posted to The Dermatology Digest.

Psoriasis and Psoriatic Arthritis in Patients With Skin of Color

By Video Pearls

psoriasis and psoriatic arthritis in patients with skin of color

In a video interview at our sister conference, Skin of Color Update, Mona Shahriari, MD, FAAD, encouraged dermatology clinicians to broaden the psoriasis color palette. She says recognizing the skin tone differences in the presentation of psoriasis can improve diagnosis and care. Dr. Shahriari is associate clinical professor of dermatology at Yale University School of Medicine.

Watch as she shares:

  • The role of biopsy when diagnosing psoriasis in skin of color
  • Challenges in diagnosing psoriatic arthritis in patients with darker skin tones
  • Latest research in treating scalp psoriasis
  • Pigmentary sequelae and the quality of life impact

If you’re committed to providing quality psoriasis care for all of your patients, this is a must-view video.

Topical Nonsteroidal Therapies for Atopic Dermatitis

By Patient Care

topical nonsteroidal therapies

A new consensus in the Journal of Drugs in Dermatology recommends advanced nonsteroidal topicals — topical JAK inhibitors, aryl hydrocarbon receptor agonists, and PDE‑4 inhibitors — as frontline therapy for AD over traditional topical corticosteroids.

In an interview with Next Steps in Derm, author Christopher Bunick, MD, PhD, shares the panel’s evidence‑based process, graded recommendations, and practical implications for clinic.

Why this matters:

  • These agents offer improved efficacy and safety vs. steroids, especially on thin or sensitive skin (face, folds, genitalia).
  • They better control itch, inflammation, and barrier dysfunction — translating to real gains in sleep and quality of life.
  • Their safety profile supports longer‑term use and easier patient adherence.
  • The consensus provides actionable guidance on where nonsteroidal topicals fit alongside biologics and small molecules.

This interview is a must‑read to update your treatment algorithms and patient counseling.

A Dermatology & Dermatopathology Approach to Systemic Disease

By ODAC Sessions

clinicopathologic correlation

At ODAC, Olayemi Sokumbi, MD, FAAD, delivered a masterclass in clinicopathologic correlation — a timely reminder that careful clinicopathologic thinking changes diagnoses, management, and outcomes. Through two cases, Dr. Sokumbi outlined how clinicopathologic correlation is a clinical imperative:

  • Case 1: Flesh‑colored papules initially called “skin tags” were reclassified as multicentric reticulohistiocytosis after integrating distribution, clinical course (periungual/hand involvement, inflammatory arthritis), and histology — a diagnosis with major implications for arthritis management and malignancy screening.
  • Case 2: Subtle, diffuse skin discoloration with otherwise non‑diagnostic biopsies was clarified by elastic tissue stain to be ochronosis due to alkaptonuria, prompting genetic and systemic workup.

These cases illustrate how dermatologists and dermatopathologists can be the first to uncover multisystem disease and steer timely, life‑altering care.

Practical reminders: Don’t be afraid to re‑biopsy, use targeted IHC and special stains, and maintain close dermatopathology collaboration. Persistence and multidisciplinary care are often the key.